Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

4-Aminopyridine Sustained Release

Known as: 4 Aminopyridine Sustained Release, Sustained Release, 4-Aminopyridine, Fampridine SR 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dalfampridine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS.
BACKGROUND Cognitive fatigue (CF) is a common complaint in persons with MS (PwMS). Fampridine-SR improves ambulation, fatigue and… Expand
  • figure 1
  • table 1
  • table 3
  • table 4
  • table 2
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Quantitative assessment of sustained‐release 4‐aminopyridine for symptomatic treatment of multiple sclerosis
Objective To evaluate the efficacy of 4-aminopyridine sustained release (4AP SR) (fampridine, EL-970) using quantitative measures… Expand
  • figure 2
  • figure 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE